The Spanish Agency for Medicines and Health Products (AEMPS) has ordered the Ban on the marketing and recall of 'Yohimnine + Caffeine' capsules, indicated for improve sexual function, for being marketed as a food supplement.
In a statement, the AEMPS explains that this product contains yohimbine in a dose that confers the medication condition, without having been subject to evaluation and authorization by the Agency.
The British company Magnus Supplements Ltd markets this product through different websites aimed at Spanish users and consumers with the active substance yohimbine in sufficient quantity to "restore, correct or modify a physiological function by exerting a pharmacological action, which gives it the legal status of a drug ".
At low doses, yohimbine is a hypertensive, while if used in higher doses it acts as a hypotensive and vasodilator of the peripheral vascular territories, so it can improve sexual function, as well as increase intestinal tone and motility.
Health alerts that in Spain there is no authorized medicine that includes yohimbine in its composition, contrary to what happens in France, where it is used for the treatment of erectile dysfunction, among others. The technical data sheet of the product in France lists a series of adverse events related to its use, including central nervous system disorders, irritability, insomnia, tremor, or cardiovascular problems. In addition, it has drug interactions with clonidine and inhibition of the activity of antihypertensive drugs.